 Franklin Wright
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 7 | 2022 | 772 | 0.970 |
Why?
| | Resuscitation | 4 | 2021 | 253 | 0.810 |
Why?
| | Blood Coagulation Tests | 1 | 2020 | 58 | 0.740 |
Why?
| | Hemorrhage | 3 | 2023 | 623 | 0.710 |
Why?
| | Blood Transfusion | 4 | 2023 | 306 | 0.710 |
Why?
| | Thromboembolism | 1 | 2020 | 99 | 0.690 |
Why?
| | Trauma Severity Indices | 1 | 2019 | 127 | 0.690 |
Why?
| | Blood Component Transfusion | 2 | 2021 | 84 | 0.680 |
Why?
| | Extremities | 1 | 2019 | 113 | 0.660 |
Why?
| | Fibrinolysis | 1 | 2020 | 159 | 0.650 |
Why?
| | Hypocalcemia | 3 | 2023 | 31 | 0.620 |
Why?
| | Shock, Hemorrhagic | 2 | 2019 | 206 | 0.610 |
Why?
| | Plasma | 1 | 2018 | 224 | 0.580 |
Why?
| | Triage | 1 | 2018 | 203 | 0.560 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 348 | 0.510 |
Why?
| | Coronavirus Infections | 1 | 2020 | 339 | 0.510 |
Why?
| | Interleukin-1beta | 1 | 2014 | 379 | 0.430 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1175 | 0.410 |
Why?
| | Tissue Plasminogen Activator | 2 | 2021 | 230 | 0.350 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1323 | 0.330 |
Why?
| | Trauma Centers | 3 | 2022 | 388 | 0.330 |
Why?
| | Saline Solution, Hypertonic | 3 | 2014 | 56 | 0.320 |
Why?
| | Wounds, Penetrating | 2 | 2019 | 77 | 0.260 |
Why?
| | Lung | 2 | 2014 | 3666 | 0.240 |
Why?
| | Thoracostomy | 1 | 2004 | 18 | 0.240 |
Why?
| | Inflammation | 1 | 2014 | 2571 | 0.240 |
Why?
| | Partial Thromboplastin Time | 2 | 2021 | 52 | 0.240 |
Why?
| | Injury Severity Score | 3 | 2022 | 528 | 0.230 |
Why?
| | Hemostatics | 1 | 2004 | 50 | 0.230 |
Why?
| | Wounds, Gunshot | 2 | 2019 | 176 | 0.230 |
Why?
| | Pandemics | 2 | 2021 | 1355 | 0.210 |
Why?
| | Advance Directives | 1 | 2022 | 62 | 0.200 |
Why?
| | Transfusion Reaction | 1 | 2021 | 79 | 0.200 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2020 | 8 | 0.190 |
Why?
| | Adult | 10 | 2022 | 31525 | 0.180 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 79 | 0.180 |
Why?
| | Calcium | 2 | 2023 | 1171 | 0.170 |
Why?
| | Critical Illness | 2 | 2021 | 663 | 0.170 |
Why?
| | Middle Aged | 8 | 2021 | 27627 | 0.170 |
Why?
| | Thrombelastography | 1 | 2020 | 192 | 0.170 |
Why?
| | Retrospective Studies | 6 | 2022 | 12990 | 0.170 |
Why?
| | NF-kappa B | 2 | 2014 | 670 | 0.160 |
Why?
| | Thrombosis | 1 | 2021 | 309 | 0.160 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 290 | 0.160 |
Why?
| | Clinical Protocols | 1 | 2018 | 238 | 0.150 |
Why?
| | Betacoronavirus | 1 | 2020 | 254 | 0.150 |
Why?
| | Violence | 1 | 2019 | 218 | 0.150 |
Why?
| | Sensitivity and Specificity | 2 | 2019 | 1795 | 0.150 |
Why?
| | Oxygen | 1 | 2021 | 857 | 0.150 |
Why?
| | Renal Dialysis | 1 | 2020 | 378 | 0.140 |
Why?
| | Epithelial Cells | 2 | 2014 | 963 | 0.140 |
Why?
| | Male | 11 | 2022 | 57818 | 0.140 |
Why?
| | Humans | 18 | 2023 | 119032 | 0.140 |
Why?
| | Intensive Care Units | 1 | 2020 | 635 | 0.140 |
Why?
| | Quality Improvement | 2 | 2021 | 963 | 0.130 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 82 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1868 | 0.120 |
Why?
| | Female | 9 | 2022 | 61588 | 0.120 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2012 | 25 | 0.110 |
Why?
| | Phosphorylation | 2 | 2014 | 1634 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2022 | 6562 | 0.110 |
Why?
| | Emergency Medical Services | 1 | 2019 | 589 | 0.110 |
Why?
| | Aged | 6 | 2022 | 19661 | 0.100 |
Why?
| | Cell Line | 2 | 2014 | 2707 | 0.100 |
Why?
| | Liver Transplantation | 2 | 2008 | 847 | 0.090 |
Why?
| | Colorado | 1 | 2019 | 4196 | 0.090 |
Why?
| | Risk Factors | 2 | 2020 | 9003 | 0.090 |
Why?
| | Stroke | 1 | 2018 | 1046 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 310 | 0.080 |
Why?
| | Hepatitis, Autoimmune | 1 | 2008 | 33 | 0.080 |
Why?
| | Liver Failure | 1 | 2008 | 85 | 0.080 |
Why?
| | Respiration, Artificial | 2 | 2022 | 545 | 0.080 |
Why?
| | Incidence | 3 | 2022 | 2424 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2007 | 227 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 521 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2007 | 527 | 0.060 |
Why?
| | Calcium, Dietary | 1 | 2023 | 55 | 0.050 |
Why?
| | Reoperation | 1 | 2004 | 557 | 0.050 |
Why?
| | Signal Transduction | 1 | 2014 | 4713 | 0.050 |
Why?
| | Oximetry | 1 | 2021 | 84 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2021 | 4596 | 0.050 |
Why?
| | Hyperoxia | 1 | 2021 | 97 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 122 | 0.050 |
Why?
| | Fibrinolytic Agents | 1 | 2021 | 237 | 0.040 |
Why?
| | Terminal Care | 1 | 2022 | 187 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 6477 | 0.040 |
Why?
| | Homicide | 1 | 2019 | 53 | 0.040 |
Why?
| | Decision Support Systems, Clinical | 1 | 2021 | 178 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2022 | 814 | 0.040 |
Why?
| | Intracranial Hemorrhages | 1 | 2018 | 77 | 0.040 |
Why?
| | United Kingdom | 1 | 2018 | 236 | 0.040 |
Why?
| | Length of Stay | 1 | 2022 | 1031 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2021 | 523 | 0.040 |
Why?
| | Pilot Projects | 1 | 2021 | 1420 | 0.040 |
Why?
| | Young Adult | 2 | 2021 | 10799 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2021 | 9346 | 0.030 |
Why?
| | Life Style | 1 | 2018 | 431 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 809 | 0.030 |
Why?
| | Hypoxia | 1 | 2021 | 963 | 0.030 |
Why?
| | Registries | 1 | 2022 | 1810 | 0.030 |
Why?
| | Brain Ischemia | 1 | 2018 | 309 | 0.030 |
Why?
| | Immunosuppressive Agents | 2 | 2008 | 683 | 0.030 |
Why?
| | Hospitalization | 1 | 2022 | 1785 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2012 | 97 | 0.030 |
Why?
| | Nebulizers and Vaporizers | 1 | 2012 | 82 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2012 | 190 | 0.030 |
Why?
| | Random Allocation | 1 | 2012 | 349 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4552 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 656 | 0.020 |
Why?
| | Smoking | 1 | 2018 | 1487 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 613 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 945 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1691 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 18483 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 412 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 412 | 0.020 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2007 | 51 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2478 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2008 | 649 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1195 | 0.020 |
Why?
| | Sirolimus | 1 | 2007 | 195 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2007 | 462 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1047 | 0.020 |
Why?
| | Blood Vessels | 1 | 2007 | 187 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2009 | 1085 | 0.020 |
Why?
| | Recurrence | 1 | 2008 | 975 | 0.020 |
Why?
| | Preoperative Care | 1 | 2007 | 332 | 0.020 |
Why?
| | Obesity | 1 | 2018 | 2751 | 0.020 |
Why?
| | Survival Analysis | 1 | 2007 | 1267 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5394 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1223 | 0.010 |
Why?
| | United States | 1 | 2019 | 12557 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 3730 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 900 | 0.010 |
Why?
| | Liver | 1 | 2007 | 1816 | 0.010 |
Why?
| | Cohort Studies | 1 | 2008 | 5117 | 0.010 |
Why?
| | Animals | 1 | 2012 | 33399 | 0.010 |
Why?
|
|
Wright's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|